Found: 4
Select item for more details and to access through your institution.
Requirement for YAP1 signaling in myxoid liposarcoma.
- Published in:
- EMBO Molecular Medicine, 2019, v. 11, n. 5, p. 1, doi. 10.15252/emmm.201809889
- By:
- Publication type:
- Article
Prevalence of the Hippo Effectors YAP1/TAZ in Tumors of Soft Tissue and Bone.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-56247-8
- By:
- Publication type:
- Article
SS18-SSX drives CREB activation in synovial sarcoma.
- Published in:
- Cellular Oncology (2211-3428), 2022, v. 45, n. 3, p. 399, doi. 10.1007/s13402-022-00673-w
- By:
- Publication type:
- Article
Fusion protein-driven IGF-IR/PI3K/AKT signals deregulate Hippo pathway promoting oncogenic cooperation of YAP1 and FUS-DDIT3 in myxoid liposarcoma.
- Published in:
- Oncogenesis, 2022, v. 11, n. 1, p. 1, doi. 10.1038/s41389-022-00394-7
- By:
- Publication type:
- Article